Loading the session
Loading the session
Loading instrument
$26.35
−0.38%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +21.1% (SPY −1.6%, XLV +13.5%). 3 months: +1.1% (SPY −0.4%, XLV +15.5%). 1 year: −42.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: AORT, SPY and XLV · as of 4 Nov 2026
The 4 Nov 2026 gain of 11.6% was 5.6× its average daily move of 2.1% over the past year, and its largest one-day gain since 8 Aug 2025.
Daily closes, split-adjusted · as of 4 Nov 2026
3.7M shares were sold short at the 15 Oct 2026 settlement, 7.7% of the 48.8M shares outstanding; covering them would take 7.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
The 4 Nov 2026 close of $26.45 was 11.5% above its 50-day average ($23.72) and 9.1% below its 200-day average ($29.11). It has closed below the 200-day for 183 sessions, since 13 Feb 2026. The 50-day average crossed below the 200-day on 19 Mar 2026, 159 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Closed at $26.45 on 4 Nov 2026: 45.2% below the 52-week high of $48.25 (17 Dec 2025) and 38.0% above the low of $19.16 (8 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
May 8, 2026
−28.26%August 8, 2025
+25.23%September 23, 2022
−28.05%